BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Karantanos T, Jain T, Moliterno AR, Jones RJ, DeZern AE. Sex-Related Differences in Chronic Myeloid Neoplasms: From the Clinical Observation to the Underlying Biology. Int J Mol Sci 2021;22:2595. [PMID: 33807519 DOI: 10.3390/ijms22052595] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Lesegretain A, Brunner A, King AJ, Laadem A, Fell G, Fathi AT. Comparison of demographics, disease characteristics, and outcomes between Black and White patients with myelodysplastic syndromes: A population-based study. Leuk Res 2023;125:107006. [PMID: 36580877 DOI: 10.1016/j.leukres.2022.107006] [Reference Citation Analysis]
2 Kamphuis P, van Zeventer IA, de Graaf AO, Salzbrunn JB, van Bergen MGJM, Dinmohamed AG, van der Reijden BA, Schuringa JJ, Jansen JH, Huls G. Sex Differences in the Spectrum of Clonal Hematopoiesis. Hemasphere 2023;7:e832. [PMID: 36713353 DOI: 10.1097/HS9.0000000000000832] [Reference Citation Analysis]
3 Tinsley-Vance SM, Ali NA, Ball S, Aguirre LE, Jain AG, Hussaini MO, Chan O, Kuykendall A, Sweet K, Lancet J, Padron E, Sallman DA, Komrokji RS. Sex Disparities in Myelodysplastic Syndromes: Genotype, Phenotype, and Outcomes. Clin Lymphoma Myeloma Leuk 2023:S2152-2650(23)00020-4. [PMID: 36813626 DOI: 10.1016/j.clml.2023.01.007] [Reference Citation Analysis]
4 Garsetti DE, Sahay K, Wang Y, Rogers MB. Sex and the basal mRNA synthesis machinery. WIREs RNA 2022. [DOI: 10.1002/wrna.1765] [Reference Citation Analysis]
5 Karantanou C, Minciacchi VR, Karantanos T. Extracellular Vesicles in Myeloid Neoplasms. Int J Mol Sci 2022;23:8827. [PMID: 35955960 DOI: 10.3390/ijms23158827] [Reference Citation Analysis]
6 Karantanos T, Teodorescu P, Perkins B, Christodoulou I, Esteb C, Varadhan R, Helmenstine E, Rajkhowa T, Paun BC, Bonifant C, Dalton WB, Gondek LP, Moliterno AR, Levis MJ, Ghiaur G, Jones RJ. The role of the atypical chemokine receptor CCRL2 in myelodysplastic syndrome and secondary acute myeloid leukemia. Sci Adv 2022;8:eabl8952. [PMID: 35179961 DOI: 10.1126/sciadv.abl8952] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Bolourian A, Shen J, Gharagozloo M, Mojtahedi Z. 1Menstruation: a possible independent health promoter, aging and COVID-19. Caspian J Intern Med 2022;13:155-60. [PMID: 35872674 DOI: 10.22088/cjim.13.0.155] [Reference Citation Analysis]
8 Catani L, Cavo M, Palandri F. The Power of Extracellular Vesicles in Myeloproliferative Neoplasms: "Crafting" a Microenvironment That Matters. Cells 2021;10:2316. [PMID: 34571965 DOI: 10.3390/cells10092316] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
9 Karantanos T, Teodorescu P, Perkins B, Christodoulou I, Esteb C, Varadhan R, Helmenstine E, Rajkhowa T, Paun BC, Bonifant C, Dalton WB, Gondek LP, Moliterno AR, Levis MJ, Ghiaur G, Jones RJ. The role of the atypical chemokine receptor CCRL2 in myelodysplastic syndrome and secondary acute myeloid leukemia.. [DOI: 10.1101/2021.07.29.454394] [Reference Citation Analysis]